TopologView all posts »
Low-dose aspirin for primary preventionJun 17, 2009 14:03 EDT
A new meta-analysis questions the use of low-dose aspirin for the prevention of cardiovascular events. Given its current wide use, these findings are important and have far-reaching consequences. What are your thoughts?
Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-1860.